Participating Countries

Australia Denmark FinlandGermany Iceland Latvia LithuaniaNew Zealand Norway  Serbia Sweden United Kingdom



Study Principal Investigator: Felix Böhm, MD, PhD
Department of Cardiology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.

Study Co-investigator: Andreas Rück, MD, PhD
Department of Cardiology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.

Study Chair: Stefan James, MD, Professor
Department of Medical Sciences, Uppsala University, Sweden.

 

Sponsor: Karolinska University Hospital, Stockholm, Sweden.

Steering committee: One investigator from each site will be represented.

Participating sites: Click on the flags on the Starting page.

 

National coordinators

Sweden: Andreas Rück, Karolinska University Hopsital, Stockholm

Denmark: Thomas Engstrøm, Rigshospitalet, Copenhagen

Finland: Mika Laine, Helsinki University Hospital

Latvia: Andrejs Ērglis, Riga

Australia: Carl Schultz, Perth

Serbia: Goran Stankovic, Belgrade

New Zealand: Madhav Menon, Hamilton

 

FULL REVASC Study team

Uppsala Clinical Research Center (UCR), Uppsala, Sweden:

Project manager: Azar Pettersson, fullrevasc@ucr.uu.se

Monitor: Åsa Michelgård Palmquist, fullrevasc@ucr.uu.se

Data manager: Åsa Eck

Statistician: Ollie Östlund

Clinical Events Adjudication (CEA) Chairman: Claes Held

Health economist: Sophie Langenskiöld, Uppsala University


DSMB: Nico Pijls (The Netherlands), Bernard De Bruyne (Belgium), Nils Johnson (USA), William F Fearon (USA).

 

We use cookies
Cookies make this site work properly. By continuing to use the site, you agree that we use cookies.